相关实验视频

Updated: Jan 15, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

针对针对性T细胞癌症治疗的CD5CAR-NK细胞中的微调信号强度

Seona Jo^1,2, Yu Bin Lee^3,4, Seok Min Kim¹

¹Center for Gene and Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.

Frontiers in immunology

|October 6, 2025

概括

优化的CD5仿真抗原受体 (CAR) -自然杀手 (NK) 细胞选择性地向具有强大的抗瘤活性和最小的瘤外毒性T细胞恶性瘤. 微调CAR信号强度是安全有效的癌症治疗的关键.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

血性T细胞恶性瘤是一种具有挑战性的治疗结果的侵袭性血液癌症.
目前的仿真抗原受体 (CAR) -T和自然杀手 (NK) 疗法显示出希望,但在非选择性瘤向和消除方面面临问题.
微调CAR信号强度和表达水平对于选择性癌细胞识别和最大限度地减少瘤外毒性至关重要.

研究的目的:

开发优化的CD5CAR-NK细胞 (OptiCAR-NK) 以对抗T细胞恶性瘤具有强大的抗瘤活性.
通过精确控制CAR信号强度和表达水平,最大限度地降低瘤外毒性.
在临床前模型中评估OptiCAR-NK细胞的治疗疗效和安全性.

主要方法:

设计的CD5CAR-NK细胞具有不同的scFv和CAR表达水平.
通过单细胞分离和mRNA转染进行调节的CAR表达,用于体外评估.
在异种移植和人性化小鼠模型中验证了治疗疗效和安全性.

主要成果:

优化的scFv和CAR表达水平 (OptiCAR-NK) 能够对CD5+恶性T细胞进行选择性向.
在临床前模型中达到强大的抗瘤活性,毒性最小.
证明NK细胞的分辨能力依赖于微调的CAR信号强度和向细胞连接体.

结论:

优化scFv和CAR表达的调制对于开发安全有效的基于CAR的疗法至关重要.
OptiCAR-NK细胞代表了一种有前途的治疗策略,用于管理T细胞恶性瘤,减少了瘤外影响.

关键词:

一个 CAR 表达式的 CAR 表达式.卡尔-NK 是一个卡尔-NK.CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 CD5 在T细胞恶性瘤中.在位上,瘤外的毒性 scFvv 在线阅读

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...